OXFORD, England, May 12, 2010 /PRNewswire/ -- PharmaTelevision(R) announced that as of today the groundbreaking online TV channel for the BioPharma industry, is teaming up with Reuters Insider, a new interactive on-demand video platform designed to change the way financial professionals consume and distribute news, research and information.
Today's generation of financial professionals access and act on information in a whole new way, said Devin Wenig, CEO, Thomson Reuters Markets. Reuters Insider was built to give our clients a competitive advantage and arm them with the multimedia tools needed to work faster and smarter.
As a content partner with Reuters Insider, this is a match made in heaven, said Doug Cookson, Commercial Director, PharmaVentures. PharmaTelevision provides a unique service for the biopharmaceutical industry providing daily television news, analysis and feature interviews with industry leaders and the relationship with Reuters Insider now allows the Financial Communities around the world to have easy access to this content
Anne Vindenes Allen, Managing Director, PharmaTelevision added. This exciting relationship is now providing a clear channel for the Biopharmaceutical Industry to provide insight, particularly through our Financial Reports, in an impactful manner, to potentially hundreds of thousands of critical stakeholders in the financial sector
PharmaTelevision is produced by professional television industry experts using professional studios worldwide as well as its own studios in the UK.
PharmaTelevision produces Open Content as well as subscription based Premium Content.
PharmaTelevision Open Content includes the Regional Report - a programme that focuses on the key locations for pharmaceutical and biotech investment, the Financial Report - a programme focused on companies and their performance and the Business Network - a series of interviews and profiles of some of the leading companies in biotech.
PharmaTelevision Premium Content includes PharmaTelevision News - a daily news and analysis programme, PharmaTelevision News Review - a programme featuring interviews, panel discussions and analysis with leading experts and leaders in our industry and the Business Report - a programme that analyses key business and market trends in our industry.
PharmaTelevision(R) is a registered Trade Mark of PharmaVentures Ltd.
For more information contact: Doug Cookson, Commercial Director, PharmaVentures Ltd +44(0)1865-332-731 doug.cookson@pharmaventures.com
SOURCE: PharmaTelevision Ltd
CONTACT: For more information contact: Doug Cookson, Commercial Director,PharmaVentures Ltd, +44(0)1865-332-731, doug.cookson@pharmaventures.com
Comments